Does this mean that Spironolactone will not cause fat redistribution either?Lol, no. Your face will remain the same. Spironolactone has little to no effect on appearance of male individuals, mostly because it just lowers testosterone a little, and binds to androgen and estrogen receptors a little. It possibly can't effect formation of DHT much, and presumably has lower binding capacity than DHT. Moreover, androgens have many permanent effects on male bodies, mostly because of the coactivator function, which initiates a cascade of effects after binding to the androgen receptors even if it's just for once. Henceforth, the gene expression is permanently turned on, until you put something in there to stop the gene expression, like a dioxin, more preferably attached to androgen receptors. It can be made receptor specific by using testosterone-dioxin, but it is definitely not recommended to anyone. Another way to mess up the gene expression is to prevent the transcription of virilization genes via corepressor function of a compound that attaches to the very same receptors.
Lucky for you, Spironolactone is neither a dioxin nor possesses corepressor function. On contraire, Bicalutamide has corepressor function, so the probability of having those permanent effects reversed is slightly increased, though not well established, because it's dealing with gene expression only via partial hindrance to transcription.